The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

There are still no vaccines for most neglected tropical diseases. Read more at straitstimes.com. Read more at ...

U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

A Federal Court judge has tossed out a challenge that would have stopped the killing of about 400 ostriches on a British Columbia farm that suffered an outbreak of avian flu.

New recommendations from the National Academies of Sciences, Engineering, and Medicine are asking scientists to dive into ...

Centres for Disease Control and Prevention (CDC) has issued an advisory urging American travellers over the age of 60 years ...

The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...